COSDERMINDIA 2025 once again proved to be a premier convergence of innovation, science, and marketing brilliance in dermatology. Held in Delhi, the event brought together leading dermatologists, pharma leaders, skincare innovators, and medical communication experts.
This year, the eMediWrite team had the privilege of being invited to meet with key marketing heads, brand managers, and senior leadership teams from top pharmaceutical and cosmeceutical companies. Our purpose? To engage in high-value conversations around brand strategy, scientific publications, and omnichannel communication planning for the upcoming year.
A Thriving Ground for Strategic Collaborations
A Thriving Ground for Strategic CollaborationsAs India’s trusted partner in medical communication and publication management, eMediWrite’s presence at COSDERMINDIA 2025 was a natural fit. The dermatology and skincare segment is evolving rapidly with new molecules, combination therapies, and changing consumer expectations. In such a dynamic space, the need for credible, creative, and compliant communication has never been greater.
We were excited to sit down with multiple pharma teams to discuss upcoming product launches, publication plans, CME support, KOL engagement strategies, and the growing demand for real-world evidence storytelling. Our conversations often extended beyond content, touching the core of positioning, brand tonality, and multi-platform medical visibility.
Driving the Dialogue: Publications, Platforms, & Personalization
From advisory board meeting summaries to structured publication roadmaps, our consultations emphasized how strategic scientific content can directly impact brand equity and HCP trust. We also offered insights on:
Journal publication planning (Q1 to Q4 2025)
Post-marketing study communication
Medical education modules for internal teams
Digital content calendars aligned with congress and dermatology updates
Whether it was a premium anti-fungal brand, a dermato-cosmetic new entrant, or a legacy skin treatment brand preparing for a relaunch, we were able to tailor our guidance to each brand’s maturity and marketing goals.
A Growing Role in Dermatology Brand-Building
We’re humbled to see how eMediWrite’s role is evolving not just as a content partner but as a strategic collaborator. COSDERMINDIA 2025 validated that more and more pharma companies are now seeking integrated medical communication support that blends scientific rigor with creative precision.
As we look ahead to 2025, our commitment remains stronger than ever, to help brands educate, elevate, and ethically grow.
If you’re a pharma leader, marketer, or medical affairs team looking to reimagine your dermatology content ecosystem, let’s talk. Together, we can build communication that wins minds and markets.
